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ABSTRACT  
Monoterpenoids offer potential as bio-derived monomer feedstocks for high performance renewable 
polymers. We describe a biocatalytic route to lactone monomers menthide and dihydrocarvide 
employing Baeyer-Villiger monooxygenases (BVMOs) from Pseudomonas sp. HI-70 (CPDMO) 
and Rhodococcus sp. Phi1 (CHMOPhi1) as an alternative to organic synthesis. The regio-selectivity 
of dihydrocarvide isomer formation was controlled by site-directed mutagenesis of three key active 
site residues in CHMOPhi1. A combination of crystal structure determination, molecular dynamics 
simulations and mechanistic modeling using density functional theory (DFT) on a range of models 
provides insight into the origins of discrimination of wild type (WT) and a variant CHMOPhi1 for 
producing different regio-isomers of the lactone product. Ring-opening polymerizations of the 
resultant lactones using mild metal-organic catalysts demonstrate their utility in polymer 
production. This semi-synthetic approach utilizing a biocatalytic step, non-petroleum feedstocks 
and mild polymerization catalysts, allows access to known and also to previously unreported and 
potentially novel lactone monomers and polymers.  
INTRODUCTION 
There is an increasing demand for the production of biodegradable plastics from renewable 
feedstocks due to both dwindling fossil fuel supplies and environmental concerns over the 
accumulation of petroleum-based non-recyclable plastic waste.1-3 This has led to the development 
biodegradable polymeric materials, including elastomers, plastics, hydrogels, flexible electronics, 
resins, engineering polymers and composites.4 Cyclic esters (lactones) have been widely used in the 
synthesis of biodegradable polymers, such as poly-ε-caprolactone (PCL)5 and polylactide (PLA) 
and related copolymers6-10, which are employed in a number of biomedical and pharmaceutical 
applications such as in drug delivery and tissue engineering11-14 and constitute the major component 
of many types of polyurethane biopolymers.15  
Other bio-derived monomers of commercial interest are monoterpenoids, which generate polymers 
such as polymenthide (PM), polydihydrocarvide (PDC) and polycarvomenthide (PCM) and related 
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ABA block copolymers of polylactide-polymenthide-polylactide triblocks (PLA–PM–PLA). These 
polymers have applications as thermoplastic elastomers and components of pressure sensitive 
adhesives.7, 15-17 Hybrid copolymers of PLA –PM-PLA triblocks are useful in pressure-sensitive 
adhesives formulations, as they have high-performing thermoplastic elastomer properties 
comparable to styrenic triblock copolymers.7-9, 17 
Monomeric compounds can be derived from either natural sources, or as reported more recently via 
metabolic engineering of microorganisms to generate industrially viable biosynthetic routes.18 
Currently the lactones menthide and dihydrocarvide are sourced primarily through chemical 
Baeyer-Villiger oxidation routes.19, 20 Alternatively, biocatalytic routes employing flavin-dependent 
Baeyer–Villiger monooxygenases (BVMOs)21-23 could offer an attractive strategy to access these 
monomers (Scheme 1), with the advantage of increased stereo- and enantiomeric control of the 
product.24-27 This was first reported by Alphand and Furstoss and further investigated in more detail 
by the Mihovilovic group. 28, 29 The BVMO reaction is often regio-divergent, generating two 
lactone products, known as the ‘normal’ and ‘abnormal’ isomers (as in Scheme 1).29 Therefore, 
candidates from the BVMO family could be selected as biocatalysts based on their enantio- and 
regio-selectivity for the production of targeted lactone monomers for polymer synthesis. 
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Scheme 1. Semisynthetic polymer production using lactone monomers.  
Semisynthetic polymer production via BVMO-catalyzed lactone production coupled with ROP oxidation 
using Mg(BHT)2(THF)2 and  benzyl alcohol.30 A) Polymenthide, B) Polydihydrocarvide. The abnormal 
lactone of (2R,5R)-(+)-dihydrocarvone is (3S,6R)-3-methyl-6-(prop-1-en-2-yl)oxepan-2-one. C) The BVMO 
reaction with (+)-pulegone. The normal lactone of (+)-pulegone is (R)-4-methyl-7-(propan-2-
ylidene)oxepan-2-one. The ROP of the lactone of (+)-pulegone was unsuccessful. 
 
Ring-opening polymerization (ROP) reactions of lactone monomers are a common strategy to 
access polymers such as PM and PDC and similar polymers such as PCL and β-pinene.7, 15, 19, 20, 31 
The use of metal catalysts for the polymerization of ε-caprolactone, menthide, dihydrocarvide and 
carvomenthide is well established.32-34 Alternatively, enzymatic approaches employing lipase 
enzymes have been reported for low molecular weight polylactide production.35, 36 
This report describes an alternative route to lactone-based biopolymers by employing a biocatalytic 
lactone production step using BVMOs with ROP using mild metal-organic catalysts. This approach 
utilizes bio-derived monoterpenoid starting materials to generate lactone monomers using the 
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BVMO enzymes cyclopentadecanone monooxygenase (CPDMO) from Pseudomonas sp. HI-7037 
and cyclohexanone monooxygenase from Rhodococcus sp. Phi1 (CHMOPhi1).38 To enable the 
production of the ‘normal’ lactone from (+)-dihydrocarvone, we performed site-directed 
mutagenesis of CHMOPhi1, and determined the crystal structures of the wild type (WT) and variant 
enzymes. A combination of structural analyses, molecular dynamics and computational mechanistic 
studies gave insights into the mechanisms that drive the formation of abnormal and normal lactone 
from (+)-dihydrocarvone. Finally, ROP reactions using a milder metal-organic catalyst than the 
ones utilized in the current polymerization process enabled the generation of polymers that were 
characterized and analyzed. Our method provides an alternative approach to access lactone 
monomers converting low-value renewable resources into value-added polymers. 
 
MATERIALS AND METHODS 
CHMO gene syntheses and mutagenesis. The genes encoding CPDMO from Pseudomonas sp. 
HI-70 (UniProtKB: T2HVF7) and CHMOPhi1 from Rhodococcus sp. Phi1 (UniProtKB: Q84H73) 
were synthesized by GenScript (USA), employing codon optimization for increased E. coli 
expression. CPDMO was sub cloned into pET15b, incorporating an N-terminal His6-tag and 
CHMOPhi1 into pET21b with a C-terminal His6-tag. The CHMOPhi1 triple variant F249A, F280A, 
F435A (variant thereafter) was generated by QuikChange site-directed mutagenesis (Agilent) 
according to the manufacturer’s protocols. Primer sequences used for the construction of the variant 
are shown in Table S1, Supporting Information). CPDMO and both CHMOPhi1 (WT and variant) 
constructs were transformed into E. coli strains BL21(DE3) and C41(DE3), respectively, for protein 
overexpression. 
The BVMOs were purified from the cell pellets using Ni-NTA affinity chromatography according 
to the manufacturers protocols (Qiagen), followed by gel filtration for crystallography studies. 
Protein concentrations were determined by either UV-Visible spectroscopy (ε450nm = 11,300 M-1cm-
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1 for flavins) or the Bio-Rad protein assay kit. Typical cell expression yields, purities and UV/Vis 
spectrum of each BVMO can be found in Table S2 and Figures S1-S2, respectively.  
Self-sufficient biocatalyst production. Each BVMO was fused to the C-terminus of the cofactor 
regenerating enzyme (CRE) phosphite dehydrogenase from Pseudomonas stutzeri (PTDH; 
thermostable variant 18-ptxD)39-41 via a six amino acid linker (SRSAAG) as described previously.41, 
42 Constructs were generated in pET15b, which positioned the His6-tag at the N-terminus of PTDH. 
Each CRE-BVMO was transformed into E. coli strain BL21(DE3) for protein overexpression (see 
Supporting Information for details). 
Analytical scale biotransformations. Biotransformations (1 mL) with either purified BVMOs (2 
µM) or cell-free extracts, CFEs (50 µL) were performed in buffer (50 mM Tris pH 7.0) containing 
substrate (5 mM unless otherwise stated) and a cofactor recycling system (15 µM NADP+, 15 mM 
glucose and 10 U glucose dehydrogenase (GDH) from Pseudomonas sp.). Reactions with CRE-
BVMOs contained sodium phosphite (100 mM) in the place of the cofactor recycling system. 
Reactions were agitated (140 rpm) for 12 h at 28 °C, and terminated by extraction with ethyl acetate 
(1 mL) containing an internal standard (0.1% sec-butyl-benzene). The extracts were dried using 
anhydrous magnesium sulfate, and analysed by GC/MS (see Supporting Information for further 
details). Quantitative analysis was carried out by a comparison of product peak areas to standards of 
known concentrations.  
Preparative scale reactions for lactone generation. Biotransformations (500 mL) were carried 
out with CRE-BVMOs (CFEs; 25 mL) in buffer (50 mM Tris pH 7.0) containing substrate (5 mM) 
and sodium phosphite (100 mM). The reactions were agitated (140 rpm) at 28 °C for 12 h followed 
by multiple ethyl acetate extractions (20 x 25 mL fractions). The pooled extracts were dried using 
anhydrous magnesium sulfate and concentrated in vacuo to give the crude lactone monomers as 
pale yellow oils. The crude samples were further purified by flash column chromatography 
(hexane:ethyl acetate, 9:1) to afford the pure lactone monomers as clear oils (46-14.5% isolated 
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yield of high purity product > 99.0%). The identity and purity of the lactone monomers produced 
were assessed by GC/MS and NMR (1H NMR and 13C NMR) analysis (Figures S3-S14).   
Lactone polymerization. The ROP of lactone monomers was performed using the metal-organic 
catalyst magnesium 2,6-di-tert-butyl-4-methylphenoxide [Mg(BHT)2(THF)2] at 80 °C as described 
previously, but conducting the reaction in 2 mL.30 Due to the oxygen and moisture sensitivity of the 
reaction, lactones were lyophilised, followed by an additional drying step over activated silica for 
48 h. ROP of the commercially available ε-caprolactone was also performed to produce PCL. 
Polymerization reactions were performed anaerobically, keeping a ratio of 50:1:1 for the 
monomers:catalyst:initiator (Table S3).The polymerization process was carried out in an oxygen- 
and moisture free environment (both < 0.5 ppm). Polymer PM was purified as reported,30 while 
PCL was purified by precipitation into hexane followed by a drying step. Purification of PDC was 
performed in a hexane/ethyl acetate (9:1) mixture, recovered from the immiscible layer and dried. 
Gel permeation chromatography (GPC) and 1H NMR spectroscopy was used to detect polymer 
formation.  
Protein crystallization and structure solution. Both CHMOPhi1 WT and variant proteins (8-10 
mg/mL) were subjected to crystallization as apoproteins and in the presence of NADP+ (2 mM). 
Crystallization drops (200 nL each of protein and reservoir solution) were generated using the 
Mosquito robot (TTP Labtech) with five screens (JCSG+, PACT Premier, SG1, Morpheus I and 
Morpheus II from Molecular Dimensions Limited) and incubated at 4°C for 1 week. The WT 
CHMOPhi1 crystallized in SG1 B5 condition (0.2 M calcium chloride and 20% w/v PEG 3350) and 
the variant crystallized in PACT Premier F2 condition (0.2 M sodium bromide, 0.1 M Bis-Tris 
propane pH 6.5 and 20% w/v PEG 3350). Plate-like crystals were cryo-protected with mother liquor 
containing 20% glycerol and flash cooled in liquid N2.  
X-ray data were collected at Diamond Light Source beamlines I03 and I04-1. Data were processed 
using xia243 implementing XDS44 and XSCALE. The WT and the variant structures of CHMOPhi1 
were solved by molecular replacement using CHMOclosed structure (PDB 3GWD) from 
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Rhodococcus sp. HI-31 as the search model in Phaser.45 The models were built using the 
AutoBuild46 wizard in Phenix.47 The models were completed using iterative rounds of model 
building using Coot48 and refinement using phenix.refine.49 The structures were analyzed using 
PDB_REDO50 server and validated using Molprobity.51 The X-ray data collection and refinement 
statistics are provided in Table 1. The atomic coordinates and structure factors have been deposited 
in the Protein Data Bank with accession codes 6ER9 and 6ERA.  
 
Table 1.  X-ray data collection and refinement statistics 
 WT CHMOPhi1 Variant CHMOPhi1  
Space group P 1 21 1 P 1 21 1 
Unit cell dimensions a=54.08 Å, b=64.44 Å, c=186.22 Å; 
α=90°, β=96.02°, γ=90° 
a=53.86 Å, b=64.94 Å,  
c=187.59 Å; α=90°,  
β=97.03°, γ=90° 
X-ray source DLS I03 DLS I04-1 
Wavelength (Å) 0.97625 0.92819 
Resolution range (Å) 92.60-2.37 (2.43-2.37)a 62.06-2.49 (2.53-2.49)a 
Completeness (%) 98.8 (99.6) 99.8 (99.9) 
Multiplicity 3.2 (3.1) 4.1 (4.1) 
I/σ I 7.9 (1.3) 9.9 (1.1) 
Rmerge 0.085 (0.727) 0.082 (0.995) 
Rmeas 0.127 (1.10) 0.094 (1.093) 
Rpim 0.070 (0.614) 0.045 (0.525) 
CC1/2 0.993 (0.523) 0.998 (0.587) 
Total observations 163400 (11814) 187824 (9073) 
Total unique 51521 (3797) 45368 (2228) 
Refinement    
R-work 0.199 0.214 
R-free 0.245 0.260 
RMS (bonds) 0.006 0.005 
RMS (angles) 0.81 0.72 
Average B-factor (Å2) 
   Average 
   FAD 
   NADP+ 
 
72.40 
46.37 
59.92 
 
84.10 
80.94 
101.58 
Ramachandran plot    
    Favored 95.93 94.12 
    Allowed 3.97 5.78 
    Outliers 0.1 0.10 
aValues in the parentheses refer to the outer resolution shell. 
 
Computational modeling. Molecular dynamics simulations were performed on WT and variant 
CHMOPhi1 in the presence of FAD and NADPH, and also in the presence of the reaction 
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intermediate. Details of the simulations performed are described in the Supporting Information 
document. Mechanistic studies used “cluster models”52, 53 and density functional theory (mPW91 + 
modified B95 (PWB6K) functional) to identify the key structural elements controlling the reactivity 
and selectivity of these biocatalysts. Details of these calculations and additional calculated data are 
summarized in the Supporting Information.  
 
RESULTS AND DISCUSSION 
BVMO selection and production. Previous studies showed that CPDMO oxidizes (-)-menthone to 
produce menthide,37 and variant CHMOs from Arthrobacter sp. BP2 (CHMOAr) and Acinetobacter 
calcoaceticus (CHMOAc) generate dihydrocarvide (the normal lactone) from (+)-dihydrocarvone.54 
A screen of in house BVMOs showed that CHMOAr and CHMOAc expressed poorly (results not 
shown), while CHMOPhi1 was highly expressed and could oxidize (2R,5R)-(+)-dihydrocarvone 
isomer (as shown in this study). Therefore CPDMO and CHMOPhi1 were chosen for further study, 
and were expressed in E. coli, purified and assessed for flavin content (UV/Vis spectroscopy; 
Figures S1-S2; Table S2).  
Given that BVMOs are NADPH-dependent, a cofactor recycling system is required to minimize the 
prohibitive costs of nicotinamide cofactor addition.55 Prior studies with six BVMOs showed that the 
fusion of the C-terminus of a thermostable variant of phosphite dehydrogenase from Pseudomonas 
stutzeri (18-ptxD PTDH)40 to the N-terminus of the monooxygenase via a six amino acid linker 
(SRSAAG) generated self-sufficient enzymes (CRE-BVMO). Cofactor regeneration during 
biotransformations was achieved via the action of PTDH with sodium phosphite.41, 42 We used this 
strategy to generate CRE-CPDMO and CRE-CHMOPhi1 (WT and variant), all were expressed in E. 
coli, purified and assessed for flavin content (UV/Vis spectroscopy; Figures S1-S2; Table S2). This 
enabled comparative biotransformations to be performed in the presence of phosphite/NADP+ 
(CRE-BVMO) or an exogenously added cofactor recycling system (glucose/GDH/NADP+; 
BVMO).  
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Biotransformations of CPDMO. Biotransformations (1 mL) of purified CPDMO with (-)-
menthone (5 mM) showed a near complete conversion to menthide, with product identification later 
confirmed by GC/MS, 1H and 13C NMR (Figure S3-S4 and S11, respectively). Similarly, reactions 
with CFEs of CPDMO or CRE-CPDMO yielded 93.5% menthide, with a minor (6.5%) secondary 
peak detected (Figure S5). Subsequent analysis showed this minor product had identical mass 
fragmentation patterns to menthide, suggesting it may be a different isomer (Figure S6).  
To assess the scale-up potential of these reactions, reactions with CRE-CPDMO extracts were 
performed with variable (-)-menthone concentrations (5-50 mM). Analytical scale reactions with 
substrate concentrations above 10 mM led to a significant decrease in product yield (Table 2). 
Larger-scale reactions were performed with CRE-CPDMO extracts (500 mL), resulting in lower 
menthide yields of 73% and the detection of the substrate isomer isomenthone (Figure S7). The 
generation of isomenthone with CRE-CPDMO extracts, but not purified protein is not surprising as 
prior studies with CFEs of E. coli showed the isomerization of menthone, and isomenthone that is  
likely to proceed via a classical glutamate racemase-type mechanism.56  
Therefore, subsequent preparative-scale biotransformation reactions were performed with 5 mM of 
(-)-menthone to both optimize menthide yield and purity. 
 
 
  
 
 
  
 
 
Table 2. Effect of substrate concentration on menthide yields with 
CRE-CPDMO. 
(-)-Menthone (mM) Conversion (%)a Menthide yield  (%)b 
5 ∼100 91.4  
10 ∼100 92.2  
25 61.8 70.7  
50 40.5 66.4  
Reactions (1 mL) were performed in buffer (100 mM sodium phosphate, 
pH 7.0) containing (-)-menthone (5-50 mM) and CRE-CPDMO CFEs at 
28 °C for 24 h. Reaction products were extracted in ethyl acetate 
containing 0.1% sec-butyl-benzene and analysed by GC/MS using a DB-
Wax column. a% of (-)-menthone converted to product/s. b% of 
menthide in the product/s. 
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Biotransformations of CHMOPhi1. GC/MS analysis of biotransformations of purified WT 
CHMOPhi1 and CRE-CHMOPhi1 extracts with (+)-dihydrocarvone showed the formation of the 
‘abnormal’ lactone (3S,6R)-3-methyl-6-(prop-1-en-2-yl)oxepan-2-one); Scheme 1, Figures S9a, 
S10a. Product identification was confirmed by 1H and 13C NMR using lactone purified from larger 
scale reactions (Figure S12). However, PDC polymers require the ‘normal lactone’ dihydrocarvide 
monomer, so the regio-selectivity of CHMOPhi1 needed to be altered to enable the desired product to 
be formed. 
Prior mutagenesis studies of CHMOAr and CHMOAc showed that a substrate regio-selectivity 
change could be achieved by mutating three active site amino acids (F299A/F330A/F485A; 
CHMOAr numbering).54, 57 Homologous mutations in both enzymes led to a complete switch from 
producing the ‘abnormal’ to ‘normal’ lactone from (+)-dihydrocarvone.54 An amino acid sequence 
alignment of CHMOPhi1 with CHMOAr and CHMOAc showed moderate homology (55%; results not 
shown), enabling the 3 targeted phenylalanine residues to be identified (F249, F280 and F435). The 
homologous variant (F249A, F280A and F435A) was generated for both CHMOPhi1 and CRE-
CHMOPhi1. The variant was expressed, purified (UV/Vis spectroscopy; Figures S1-S2; Table S2) 
and tested for activity with (+)-dihydrocarvone.  
Biotransformations of variant CHMOPhi1 (both purified protein and CFEs) showed that the regio-
selectivity of the enzyme had successfully switched to forming the ‘normal’ lactone dihydrocarvide 
as the major product (Figure S9b, S10b). Product identification was confirmed by 1H and 13C NMR 
using lactone purified from larger scale reactions (Figure S13). (+)-dihydrocarvone is commercially 
available as a mixture of two isomers, the n-isomer (2R,5R) and the iso-isomer (2R,5S) at around 
77:20 ratio (Figure S8a). Interestingly, reactions of purified WT and variant CHMOPhi1 with the 
commercially available (+)-dihydrocarvone showed conversion of only the (2R,5R)-isomer (>99%; 
Figure S9a, S9b), yet both isomers appeared to be consumed in reactions containing CFEs (>99%, 
Figure S10). This is likely due to the activity of a native E. coli enzyme capable of reacting with the 
(2R,5S) isomer of (+)-dihydrocarvone. 
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Preparative-scale lactone production. Larger-scale reactions (2 x 500 mL; 5 mM substrate) were 
performed to generate both menthide and dihydrocarvide using CFEs of CRE-CPDMO and the 
CRE-CHMOPhil1 variant, respectively. Each product was solvent extracted and purified to generate 
lactone oils (> 99% purity) with yields of 403 mg of menthide (47%) and 211 mg of dihydrocarvide 
(33%).  The identity and purity of the lactones were confirmed by 1H and 13C NMR analysis (Figure 
S11 and S13).  
As further proof of principle, the same methodology was applied to generate the lactone of (+)-
pulegone ((R)-4-methyl-7-(propan-2-ylidene)oxepan-2-one), Scheme 2 and the abnormal lactone of 
(+)-dihydrocarvone, Scheme 1B using CRE-CPDMO and WT CHMOPhil1, respectively (Supporting 
Information  for more details and NMR data). The products were purified (> 99%) and the 
structures confirmed by 1H and 13C NMR analysis (Figure S12 and S14). The yield of lactone of 
(+)-pulegone and the abnormal lactone of (+)-dihydrocarvone were 121.4 mg (29.4%) and 190.1 
mg (14.4%), respectively. Optimization to improve both the product yield and recovery after 
purification would be needed to increase the applicability of biosynthetic lactone production on an 
industrial scale. 
 
Ring opening polymerization of lactone monomers. We have demonstrated the efficient 
biosynthesis of a range of monoterpenoid lactone monomers on a preparative scale. The next stage 
is to implement a more environmentally friendly ROP to further improve the production of existing 
and novel bio-based polymers. By controlling the molecular weight and composition of the 
polymers, their properties can be tailored for use in diverse applications. 58 Previous studies have 
described the synthesis and characterisation of polymers derived from menthide19, 59 and 
dihydrocarvide,20 including ROP reactions using the milder [Mg(BHT)2(THF)2] catalyst with 
menthide30 and ε-caprolactone.60  
The BVMO-derived lactones menthide, dihydrocarvide and pulegone lactone were subjected to 
ROP reactions using [Mg(BHT)2(THF)2] catalyst.30 As a control, we also performed comparative 
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ROP with commercially available ε-caprolactone, to enable a comparison of polymer sizes with 
previously published values. Each polymer was purified, and analysed by both 1H NMR 
spectroscopy (Figure S15-S16) and triple detection GPC (Figure S17-S18), to confirm the 
polymeric nature and molecular distribution of the products (Table 3). There was no evidence of 
polymer formation with the pulegone lactone (see Supporting Information for discussion).  
 
Table 3. GPC quantitative parameters of each polymer using OMISECTM Multi Detection GPC analysis. 
Polymer Mn (kDa) Mw (kDa) ĐM IV (dL/g) Rh (nm) 
Polymenthide (PM) 6.55 7.98 1.22 0.14 2.57 
Polydihydrocarvide (PDC) 6.11 7.42 1.21 0.11 2.29 
Polyε--caprolactone (PCL) 6.58 11.73 1.79 0.24 3.39 
Mw = weight average molecular weight; Mn = number average molecular weight; ĐM = sample dispersity; IV = intrinsic 
viscosity; Rh = hydrodynamic radius. The GPC was coupled with refractive index (RI), Right-Angle Light Scattering 
(RALS), Low-Angle Light Scattering (LALS) and viscometer detection. Samples were prepared in THF (3 mg/mL of 
solid polymer or 20 µL of liquid polymer/mL) and 50 µL injections of samples were separated isocratically on a set of 
standard ViscoGel columns. The columns and detectors were maintained at 35 °C. The detectors recorded the elution of 
the samples from the columns and the analysis was performed using the OMNISECTM V10.20 software. The data 
presented are the average of three measurements. The dn/dc value was fixed to 0.72 mL/g for PCL61 due to the reaction 
scale and impurities present. 
 
In each case, the NMR spectra of the derived polymers was consistent with previously published 
spectra for PM, PDC and PCL.19, 20, 30, 59, 60 The molecular mass and dispersity of purified PM 
(Table 3) was shown to be very similar to the previously described polymer generated using the 
same ROP catalyst with chemically-synthesised menthide (Mw ~ 8.0 kD; ĐM ~ 1.2).30 Therefore, the 
ROP polymerization of the bio-sourced menthide has successfully generated polymers of similar 
characteristics as PM from chemically synthesised monomers. 
Polymers of bio-derived dihydrocarvide showed a very similar molecular mass and dispersity as 
PM (Table 3). The only report of ROP using [Mg(BHT)2(THF)2] catalyst with dihydrocarvide was 
co-polymerizations with ω-pentadecalactone.30 Control PCL polymers showed similar number 
average molecular weight but broader dispersity (ĐM = 1.79) than PM and PDC (Table 3) reflective 
of a faster rate of polymerization. Previous ROP, using a manganese catalyst, gave similar PCL 
molecular masses under both aerobic and nitrogen environments.60 
 
14 
The Mark-Houwink plot was generated for the three polymers (Figure S25) showing the influence 
of lactone substitution on main chain flexibility in line with expectation (PDC > PM > PCL). This 
opens up great potential in generating de novo bio-plastics with variable properties by combining 
the strategies of BVMO-derived regio-specific lactone generation with milder ROP-based 
polymerizations. 
Crystal structure of WT and variant CHMOPhi1. To understand the role of active site residues 
F249, F280 and F435 in determining the regio-selectivity of CHMOPhi1 towards (+)-
dihydrocarvone, the crystal structures of both WT (2.4 Å) and variant (2.5 Å) were determined in 
complex with NADP+ (Figure 1). The structures were solved by molecular replacement using the 
coordinates of the closed form of CHMO from Rhodococcus sp. HI-31 (90% sequence identity) as 
the search model. Our repeated efforts to obtain structures in complex with either (+)-
dihydrocarvone or the lactone product failed.  
Both structures possessed BVMO-like Rossmann fold domains for FAD- and NADPH-binding and 
a third helical domain flanking the cofactor-binding domains (Figure 1A). Clear electron density is 
observed for FAD and NADP+ in both structures. Unusually for monomeric BVMOs, the structures 
contained two molecules in the asymmetric unit. Analysis of the dimer interface revealed no 
significant interactions between the two chains of the WT structure. The interface is significantly 
altered when compared to the one seen in the dimeric structure of 2-oxo-Δ(3)-4,5,5-
trimethylcyclopentenylacetyl-coenzyme A monooxygenase from Pseudomonas putida ATCC 
17453.62 Size exclusion chromatography showed both the WT and variant eluted from the column 
corresponding to their respective monomeric molecular weights. In addition, analysis of the 
assemblies by PISA63 gave a Complexation Significance Score (CSS) of zero for both CHMOPhi1 
structures excluding any formation of quaternary structure in solution and the observed dimeric 
arrangements are therefore crystallization artefacts. 
The WT CHMOPhi1 structure shows the presence of a well-ordered control loop (residues 489-506), 
which is implicated in the catalytic mechanism of BVMO enzymes.64 This suggests the enzyme is 
 
15 
in a ‘closed’ conformation, as it closely resembles previously described CHMOtight65 and 
CHMOclosed structures.66 In contrast, the control loop region of the variant CHMOPhi1 structure 
exhibits altered conformation and lack of electron density for residues 496-504. The altered 
residues (487-495) have significantly moved away from the active site, which resulted in the side 
chain of W493 now positioned at a distance of 6.4 Å (measured between NE atoms) from WT 
location. There is also a significant conformational change between the NADP+-binding domains of 
the two structures (Figure 1B). The movement of the NADP+-binding domains is similar to that 
observed for the Rhodococcus sp. HI-31 CHMOopen and CHMOclosed structures,66 suggesting the 
variant CHMOPhi1 structure is in an ‘open’ conformation.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Crystal structures of WT CHMO Phi1 and the F435A, F280A, F249A variant. A) Cartoon 
representation of CHMO Phi1 WT structure with the NADP+ domain is shown in blue, FAD domain in lilac 
and the helical domain in cyan. The control loop is shown as a red loop. B) Cartoon representation of an 
overlay of WT (lilac) and variant (aqua) structures of CHMOPhi1. The arrow indicates the movement of 
NADP+ domains when the FAD-domains are anchored. Active site of C) WT and D) variant CHMO Phi1 
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(chain A) structure showing side chains of key residues as lilac and aqua sticks, respectively. In all panels, 
the FAD and NADP+ are shown as atom colored sticks with orange and green carbons, respectively. 
 
There are several notable active site differences between the WT and variant structures of 
CHMOPhi1. In the WT closed structure, the nicotinamide ring of NADP+ is positioned almost 
parallel to the isoalloxazine ring of FAD, with a distance of 2.81 Å between the N7 atom of NADP+ 
and N5 of FAD. The conserved residues R330 and D60 form a salt bridge (Figure 1C), and are 
involved in the positioning of NADP+ and substrate, as noted in prior work.62 In the variant 
structure this interaction is absent, with one conformation of R330 positioned close to W493 (chain 
A, Figure 1D) and the second between mutated residues A280 and A435 (chain B; Figure 1C-D). 
Free from the salt bridge, D60 in the variant is pointing inwards into the active site. 
Variant mutations F280A and F249A are located close to the FAD and NADP+, resulting in the 
movement of the nicotinamide moiety downwards aligning with the face of the isoalloxazine ring of 
FAD and losing the interactions with S189 and N193. This change in position in the variant 
structure is likely facilitated by the displaced control loop, and has resulted in an increase in the 
distance between the NADP+ N7 atom and the FAD N5 atom to 6.4 Å. There is also a loss of the 
control loop residue W493 NE to NADP+ O3 hydrogen bond in the variant structure providing 
flexibility to the ribose moiety. Additionally, the F435A mutation has resulted in significant 
rearrangement of the nearby residues from 434 to 438, which forms the boundary to one side 
substrate binding pocket. This loop arrangement has caused the N437 side chain in the variant to 
twist horizontally towards the nicotinamide moiety and form a hydrogen bond.  
Two regions near the active site display significant backbone differences when the two structures 
were superposed. Residues 146-151 and 380-386 are positioned away from the active site in the 
variant, possibly to accommodate the new location of NADP+. It is worth noting that the observed 
backbone differences extend beyond the active site and continue to the NADP+-binding domain. In 
addition to D60, R330, N437, W493 and the three mutations discussed above, backbone differences 
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have also contributed to the change in the active site area in the variant. In particular, the side 
chains of L146 and L147 are now located considerably further away from the active site, 
contributing to the expansion of substrate binding pocket. In summary, the variant CHMOPhi1 
structure show that the three mutations have resulted in a significant increase in the overall size of 
the active site pocket, and changes in the interaction between NADP+, FAD and/or protein residues. 
Computational study of CHMOPhi1 regio-selectivity. The switch in regio-selectivity for lactone 
formation observed between WT and variant CHMOPhi1 suggests a change in the conformation(s) of 
(2R,5R)-(+)-dihydrocarvone bound in the active site. Detailed understanding of the structural and 
energetic effects of changes to the active site pocket and the interactions between cofactors, protein 
residues and substrate conformers will be important for the computational design, screening and 
optimisation of biocatalysts. Here, molecular dynamics simulations and DFT calculations on cluster 
models have been used to identify important features. The results are described briefly here, with a 
more in-depth discussion of the computational approaches used and insights gained in the 
Supporting Information.  
BVMOs catalyse the NADPH-dependent oxygen insertion into a carbon-carbon single bond of 
acyclic and cyclic ketones.67, 68 The reaction proceeds via a Criegee intermediate (Scheme 2A) The 
regio-selectivity of the reaction arises because the migrating substituent and the O-O bond of the 
peroxy group need to be anti-periplanar,69 which is controlled by the orientation of the substrate 
within the active site.54 The normal or abnormal lactone (Scheme 1) is formed dependent on 
whether oxygen insertion occurs adjacent to the more highly or less substituted carbon atom, 
respectively.54 
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Scheme 2. A) Mechanism of formation of the Criegee intermediates in the reaction between BVMO-FAD, 
NADPH, O2 and cyclohexanone. Mechanism is adapted from Yachnin, B.J. et al (2012)70 B) Molecular 
structure and conformations of (2R,5R)-(+)-dihydrocarvone.  
 
Detailed conformational studies of cyclohexanones show that the six-membered ring is likely to be 
most stable in a chair conformation,71 with the two substituents placed in either an equatorial, 
equatorial (eq, eq), or in an axial, axial (ax, ax) arrangement (Scheme 2B).72-77 For CHMOPhi1-
catalysed (+)-dihydrocarvone oxidation, only the (2R, 5R) isomer is consumed. For this isomer, the 
equatorial conformation is slightly more favorable (by 1.8 kcal/mol-1 in the isolated (2R,5R) isomer 
at the present level of theory, in agreement with molecular mechanical studies of related 
cyclohexanone75. In the cluster models of the active site considered here (Table 4 below), the 
energy preference (calculated by DFT) for the equatorial conformer increases in the reactant 
complex compared to the isolated substrate (by between 3.5 and 8.5 kcal mol-1), suggesting that the 
site is selective.  
As the crystallographic data suggested significant differences in the active site on going from WT to 
variant structures of CHMOPhi1, molecular dynamics (MD) simulations (see Supporting Information 
for details) were used to identify persistent steric interactions with the active site. Three 
independent replicas of molecular dynamics simulations were performed using the crystal structures 
 
19 
of WT and variant CHMOPhi1-NADPH-FAD without the substrate and the Criegee intermediate in 
both conformations. For the WT, this showed that the Criegee intermediate in the ax, ax 
conformation sterically clashes with nearby residues, making it less favorable than the eq, eq 
conformer. In contrast, both conformations are readily accommodated by the variant structure (see 
below and further discussion in Supporting Information for further discussion). 
Simulations with the WT enzyme showed that the Criegee intermediate in the eq, eq conformation 
was stable during the 100 ns of MD simulation in three replicas, and interacted with residues F435, 
F249, F280 and W493 (Figure 2 and S23a). In contrast, simulations with the Criegee intermediate 
in the ax, ax conformation showed a switch in conformation to the eq, eq form after 40 ns in the 
first replica, 16 ns and 21 ns in the second and third, respectively (Figure S23b). Interestingly, when 
the variant structure was used, both Criegee intermediate conformers were stable during the 
simulation time (Figure 2 and S23c-d). This may be due to the relatively larger active site cavity 
and increased flexibility of the control loop, which was seen during simulations of  the WT and 
variant CHMOPhi1 without the Criegee intermediate (Figure S22). In particular, accommodation of 
the ax, ax substrate conformer in the variant protein could be partly due to the movement of residue 
W493 (control loop residue) away from the active site.  
The MD simulations suggest that close contacts with W493 destabilise the ax, ax conformer of the 
substrate, making the WT selective for the eq, eq conformer and leading to the abnormal product. 
The mutations of F249A, F280A and F435A make the active site larger and, equally importantly, 
the control loop considerably more flexible. This suggests that both conformers, eq, eq and ax,ax, 
need to be considered to determine the balance between a kinetic preference for the normal lactone 
product and other factors (site selectivity, close contacts) which might favor the abnormal lactone 
instead. 
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Figure 2. Predictions of the binding of Criegee intermediates in CHMOPhi1. A) Predicted interactions 
between WT and variant CHMOPhi1 with the Criegee intermediates. The panels are in the same orientation. 
Criegee intermediate conformers (eq, eq and ax, ax) are shown as atom colored sticks with cyan and green 
carbons, respectively. Residues of WT and variant CHMOPhi1 are shown as atom colored sticks with pink and 
orange carbons, respectively. B) Calculated active site/Criegee intermediates in the eq, eq (left) and ax, ax 
(right) within WT CHMOPhi1 crystal structure. The orientation of the panels is slightly different to facilitate 
the viewing of the substrate interactions, especially with W493 at the top left of each panel. 
DFT calculations on a small ‘cluster’ model of the active site (M(med), see Supporting Information 
for full computational details) were used to explore selectivity and reactivity. These calculations 
were based on a previous mechanistic study of the active site, albeit with different substrates,78 and 
included the NADP+ and FADHOO- versions of the cofactors, and R330 with a protonated 
guanidium which, together with the NADP+ ribose hydroxyl groups, allows hydrogen bonds with 
the substrates. Additional calculations were performed with residue W493 in the 
crystallographically observed position (M(med_W) or in the absence of R330 (M(med_noR). 
Geometries of the reactant, Criegee intermediate, migration transition state and product were 
considered for both (2R,5R)-(+)-dihydrocarvone conformations, allowing comparison of the 
calculated potential energies (Table 4). The analyses did not model the Criegee intermediate 
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formation because previous work found this to be  energetically more accessible than the migration 
transition state for a cyclohexanone substrate.78  
Migration transition states for the regio-isomer of the lactone product in each case (where the 
migrating group is not antiperiplanar to the O-O peroxide bond) could not be accommodated in the 
cluster model, producing a range of close contacts that could not be relieved by optimisation within 
the geometry constraints used (chosen to reproduce the crystallographically-observed residue 
positions). The eq, eq conformer thus leads only to the abnormal lactone, whereas the ax, ax 
conformers gives only normal lactone. In contrast, optimization of the product complexes for both 
lactone products was successful. These active site models do not include any of the residues that 
were mutated to switch selectivity. Full structural analysis and breakdown of energies as well as a 
discussion of our approach can be found in the Supporting Information. 
 
Table 4: DFT-calculated potential energies for key stationary points (PWB6K/DZP, kcal mol-1, see SI for full 
details, method effects and structural analyses, as well as M(med_noR) data; NL denotes normal lactone, AL 
abnormal lactone). 
 
Conformer eq, eq ax, axa ax, ax onlyb 
M(med_W)    
Reactant 0.0 3.5 0.0 
Criegee IM 6.8 11.6 8.1 
Migration TSc 25.6 (AL) 35.3 (NL) 31.8 (NL) 
Product –66.7 (AL) –61.7 (NL) –65.2 (NL) 
M(med)    
Reactant 0.0 8.5  0.0 
Criegee IM 8.0  9.1  0.6 
Migration TSc 25.9 (AL)  28.4 (NL)  19.9 (NL) 
Product –67.3 (AL)  –64.0 (NL)  –72.5 (NL) 
a Energies relative to eq, eq reactant. b Energies relative to ax, ax reactant. c Only one TS could be located for each 
conformer. 
 
As discussed above and in greater detail in the SI, residue W493 is important for interactions 
between the substrate and the residues in the active site, and was therefore included in M(med_W), 
which we consider a suitable model for the WT, with M(med) a possible model for the variant in 
which this residue moves away from the reacting site.  
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Active site models of the WT  enzyme containing W493 (M(med_W)) show a clear preference for 
the eq, eq conformer of the substrate, with a lower barrier to reaction (18.8 vs 23.7 kcal moL-1 cf. 
Criegee IM) compared to the ax, ax conformer. The substrate (eq, eq) moves closer to R330 to 
relieve close contacts with W493, and possibly also F249 and F435 (Figure 2A). This model of the 
active site captures essential features of the WT enzyme. 
In the absence of W493, as could occur in the variant, but retaining R330 in the model (M(med)), 
site selectivity is actually predicted to be enhanced for the reactant complexes, increasing the 
preference for the equatorial conformer to 8.5 kcal mol-1. However, the MD simulations above and 
detailed structural analyses (see Supporting Information) suggest that interactions between the 
active site and the substrate or product are relatively weak and rely on hydrogen-bonding, making 
these calculation results noisy and more variable than for the Criegee intermediate in which the 
substrate is bound more strongly via O2. This is discussed in detail in the Supporting Information. 
We would encourage caution in over-interpretation of the reactant and product complex energies 
and their implications for selectivity. There is only a weak calculated preference for the Criegee 
intermediate of M(med) with respect to the equatorial conformer (near isoenergetic with ax, ax), 
with very similar transition state energies for the migration step (equatorial 17.9 kcal mol-1 vs. axial 
19.3 kcal mol-1 vs. the related Criegee IMs). However, when barriers to migration compared to the 
same conformer’s reactant complex are considered (considering the eq, eq and ax, ax only columns 
in Table 4), the axial conformer reacts via a lower barrier and the normal lactone product would be 
predicted to be produced in this case. This suggests the WT selectivity (modeled by M(med_W)) 
arises from a clear thermodynamic preference for the eq, eq conformer throughout, leading to the 
abnormal lactone, while the variant (modeled by M(med)) shows an erosion of the preference for 
the eq, eq conformer in the Criegee intermediate. At this stage, a switch to kinetic control may 
become possible, favoring the ax, ax conformer in the Criegee intermediate, which could then 
progress via a lower barrier to reach the migration transition state and produce the normal lactone.  
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The mutations were initially identified by Balke et al.79 after docking of the normal lactone product 
of (2R,5R)-(+)-dihydrocarvone (ax, ax substrate conformer) into protein crystal structure geometries 
of the WT; in later work, a different lactone product, from the reaction of the (2S, 5S)-(+)- 
dihydrocarvone enantiomer, was also considered.57 These considerations led the authors to propose 
the sites for mutation, aimed at opening up the active site to better accommodate the normal 
lactone, with experimental evaluation used to select the final triple site mutation (F249A, F280A, 
F435A in the organism used here).  As shown in Figure 2A for the relevant Criegee intermediates, 
these mutations do indeed give rise to a comparatively more open site. In addition, as discussed 
above, they increase the mobility of other residues, removing the W493 residue from close contacts 
in the reacting site. These changes could only be detected by MD simulation and crystallographic 
study of the variant CHMOPhi1 structure as reported here, and will probably reduce the number of 
unfavorable interactions with substrate conformers. By making the conformers more similar in 
energy to each other and so reducing inherent site selectivity, the kinetic preference for the O 
migrating to the more electron-rich 2-methyl substituent (axial conformer) becomes more 
important, producing the normal lactone. Such effects are subtle and require consideration of 
structures and reactivity. Quantifying the energy differences reliably would require extensive 
sampling (and calculations of binding affinities) rather than a cluster DFT or QM/MM calculation; 
as discussed in greater detail in the Supporting Information, this lies outside the scope of the present 
study. 
This computational analysis demonstrates the importance of considering key stationary points along 
the reaction pathway during the computational screening and design process, as the site selectivity 
for substrate and product alone is not sufficient for explaining the observed product preferences. 
The reactivity and selectivity changes are subtle, and several effects combine to give the observed 
outcome. Computational studies aimed at future design should carefully consider the whole range 
of potentially important and competing effects, of binding and reactivity. These computational 
models presented here should assist in prediction of selectivity for normal vs. abnormal lactone 
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formation by natural and designed CHMOs. This should allow extension to other potential terpene 
substrates.  
 
CONCLUSIONS 
We present a semi-synthetic approach utilising biocatalysis with non-petroleum feedstocks as a 
practical route to potentially novel lactone monomers. This approach employs BVMO enzymes 
which provide control over the enantio- and regio-specificity of monomer production. Further, we 
have combined experimental and computational approaches to investigate and analyse the causes of 
the observed selectivity.  
This interaction between structural biology, molecular dynamics simulations and quantum chemical 
models with experimental testing provides a guide for design and thus a roadmap for finding 
biocatalytic routes for the production of other monomers. We have also demonstrated that menthide 
and dihydrocarvide can be polymerized using a mild metal-organic catalyst. When combined with 
the control over isomers of the lactone monomers that biocatalysis enables, this opens up a broader 
range of polymer physical properties and behaviours for a wide range of applications.  
Our platform technology to existing and novel lactone-based polymers combines biocatalyst 
identification (and potentially future design), adaptation to optimize regio-selective control of 
monomer formation and environmentally friendly polymer chemistry. Access to existing and novel 
monomers with improved performance and functionality from feedstocks has the potential to 
transform polymer production by providing routes to their manufacture, a key element of a nascent 
circular economy.  
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